Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) — Stock Price
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) is currently trading at Rs115.61 INR, down 2.70% today. Over the past 52 weeks, shares have ranged between Rs73.76 and Rs141.38. This page tracks Lotus Eye Hospital and Institute Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Lotus Eye Hospital and Institute Limited worth.
Lotus Eye Hospital and Institute Limited (LOTUSEYE) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Lotus Eye Hospital and Institute Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Lotus Eye Hospital and Institute Limited Income Statement — Revenue, Profit & Earnings by Year
Lotus Eye Hospital and Institute Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs495.62 Million | Rs482.10 Million | Rs470.44 Million | Rs389.10 Million | Rs323.59 Million |
| Cost of Revenue | Rs395.22 Million | Rs346.44 Million | Rs349.06 Million | Rs292.35 Million | Rs237.89 Million |
| Gross Profit | Rs100.41 Million | Rs135.66 Million | Rs121.38 Million | Rs192.53 Million | Rs85.70 Million |
| Research & Development | Rs584.00K | Rs536.00K | Rs488.00K | Rs831.00K | Rs498.00K |
| SG&A | Rs23.67 Million | Rs21.80 Million | Rs20.53 Million | Rs21.54 Million | Rs5.21 Million |
| Total Operating Expenses | Rs96.14 Million | Rs35.11 Million | Rs73.82 Million | Rs62.33 Million | Rs23.91 Million |
| Operating Income | Rs4.26 Million | Rs100.55 Million | Rs47.56 Million | Rs34.67 Million | Rs13.17 Million |
| EBITDA | Rs47.44 Million | Rs79.42 Million | Rs88.37 Million | Rs68.09 Million | Rs44.59 Million |
| EBIT | Rs17.38 Million | Rs42.15 Million | Rs58.56 Million | Rs43.08 Million | Rs21.29 Million |
| Interest Expense | Rs3.55 Million | Rs2.01 Million | Rs2.04 Million | Rs2.14 Million | Rs1.37 Million |
| Income Before Tax | Rs13.83 Million | Rs40.14 Million | Rs56.52 Million | Rs40.94 Million | Rs19.92 Million |
| Income Tax Expense | Rs6.43 Million | Rs10.99 Million | Rs15.75 Million | Rs11.09 Million | Rs4.24 Million |
| Net Income | Rs7.39 Million | Rs29.14 Million | Rs40.77 Million | Rs29.84 Million | Rs15.68 Million |
Lotus Eye Hospital and Institute Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Lotus Eye Hospital and Institute Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs695.74 Million | Rs666.27 Million | Rs631.88 Million | Rs615.97 Million | Rs592.29 Million |
| Total Current Assets | Rs115.70 Million | Rs140.17 Million | Rs147.10 Million | Rs128.62 Million | Rs136.04 Million |
| Cash & Equivalents | Rs41.51 Million | Rs25.82 Million | Rs36.03 Million | Rs37.89 Million | Rs51.81 Million |
| Short-term Investments | Rs19.67 Million | Rs42.77 Million | Rs47.28 Million | Rs50.04 Million | Rs47.12 Million |
| Net Receivables | Rs13.23 Million | Rs12.58 Million | Rs11.72 Million | Rs6.80 Million | Rs7.76 Million |
| Inventory | Rs38.30 Million | Rs32.12 Million | Rs27.91 Million | Rs23.05 Million | Rs17.80 Million |
| Property, Plant & Equipment | Rs539.42 Million | Rs486.54 Million | Rs440.75 Million | Rs439.50 Million | Rs403.75 Million |
| Goodwill | — | — | Rs1.00 | — | — |
| Total Liabilities | Rs95.73 Million | Rs72.17 Million | Rs56.09 Million | Rs69.88 Million | Rs65.32 Million |
| Total Current Liabilities | Rs74.25 Million | Rs62.27 Million | Rs51.92 Million | Rs57.57 Million | Rs58.18 Million |
| Long-term Debt | Rs1.22 Million | — | — | — | Rs1.36 Million |
| Net Debt | Rs-7.21 Million | Rs-15.42 Million | Rs-24.99 Million | Rs-25.51 Million | Rs-47.82 Million |
| Total Stockholder Equity | Rs600.00 Million | Rs594.09 Million | Rs575.79 Million | Rs546.09 Million | Rs526.97 Million |
| Retained Earnings | Rs143.09 Million | Rs135.69 Million | Rs116.94 Million | Rs86.57 Million | Rs67.12 Million |
Lotus Eye Hospital and Institute Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Lotus Eye Hospital and Institute Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs27.02 Million | Rs56.83 Million | Rs43.87 Million | Rs43.94 Million | Rs27.30 Million |
| Capital Expenditures | Rs48.27 Million | Rs56.43 Million | Rs30.97 Million | Rs46.85 Million | Rs4.76 Million |
| Free Cash Flow | Rs-21.25 Million | Rs403.00K | Rs12.90 Million | Rs-2.91 Million | Rs22.55 Million |
| Investing Cash Flow | Rs-43.50 Million | Rs-46.33 Million | Rs-21.94 Million | Rs-39.18 Million | Rs4.86 Million |
| Financing Cash Flow | Rs-12.42 Million | Rs-34.02 Million | Rs-17.05 Million | Rs-15.75 Million | Rs-3.19 Million |
| Dividends Paid | Rs107.00K | Rs10.40 Million | Rs10.40 Million | Rs10.34 Million | Rs10.34 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs30.07 Million | Rs37.28 Million | Rs29.80 Million | Rs25.01 Million | Rs23.30 Million |
| Change in Cash | Rs13.87 Million | Rs-23.51 Million | Rs4.88 Million | Rs-10.99 Million | Rs28.97 Million |
Lotus Eye Hospital and Institute Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Lotus Eye Hospital and Institute Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 27, 2026 | — | — | — |
| Feb 10, 2026 | — | — | — |
| Nov 10, 2025 | — | — | — |
| Aug 12, 2025 | — | — | — |
| May 26, 2025 | — | — | — |
| Feb 12, 2025 | — | — | — |
| Nov 12, 2024 | — | — | — |